Global Proteomics Market

NEW YORK, July 9, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Proteomics Market

 

http://www.reportlinker.com/p092466/Global-Proteomics-Market.html

 

This report analyzes the worldwide markets for Proteomics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 82 companies including many key and niche players such as -

 

ActivX Biosciences, Inc.

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

Bruker Daltonics, Inc.

Caprion Proteomics, Inc.

 

 

 

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability and Reporting Limitations I-1

Disclaimers I-2

Data Interpretation & Reporting Level I-2

Quantitative Techniques & Analytics I-3

Product Definitions and Scope of Study I-3

 

 

II. EXECUTIVE SUMMARY

 

1. GLOBAL MARKET OVERVIEW II-1

Proteomics - The Current Spotlight II-1

Proteomics: A Critical Drug Discovery Tool II-2

Research to Dominate the Market in the Immediate Future II-3

Proteomics Technologies: Growing in Significance II-3

New Developments in Proteomics Technologies II-4

Market Drivers/Trends/Challenges II-5

Personalized Medicine Slowly Gaining Ground II-5

Table 1: Drug Ineffectiveness for Select Therapeutic

Categories as a Percentage of Patient Population (includes

corresponding Graph/Chart) II-5

 

Table 2: Global Population Statistics for the 65+ Age Group

(2012) (includes corresponding Graph/Chart) II-7

 

Table 3: Percentage of Population Aged 65 and Above in

Europe, US, and Japan (1960-2030) (includes corresponding

Graph/Chart) II-8

 

Table 4: Elderly Population (65+ Years) as a Percentage of

the Total Population: 2025 (includes corresponding

Graph/Chart) II-8

Advancements in Proteomics Bring Biomarkers into Limelight II-8

List of US-FDA Approved Biomarkers for Cancer II-9

Oncology - A Key Focus Area for Proteomics II-10

Table 5: World Cancer Incidence by Geographic Region and

Gender (2012): Number of New Cancer Cases Reported (in

Thousands) for Asia-Oceania, Europe, North America, Latin

America & The Caribbean, and Africa (includes corresponding

Graph/Chart) II-11

 

Table 6: New Cancer Cases in the World by Affected Site

(2012) (in Thousands) (includes corresponding Graph/Chart) II-12

 

Table 7: Cancer Incidence in Developed Nations by Site: 2012

(includes corresponding Graph/Chart) II-13

 

Table 8: Global Incidence of Common Cancers in Men (2012):

Number of New Cases Reported in Thousands for Lung &

Bronchus, Prostate, Colorectal, and Liver Cancers (includes

corresponding Graph/Chart) II-14

 

Table 9: Global Incidence of Common Cancers in Women (2012):

Number of New Cases Reported in Thousands for Breast,

Colorectal, Lung & Bronchus, and Liver Cancers (includes

corresponding Graph/Chart) II-14

 

Table 10: World Cancer Mortality by Geographic Region and

Gender (2012): Number of Cancer- Related Deaths (in

Thousands) for Asia-Oceania, Europe, North America, Latin

America & The Caribbean, and Africa (includes corresponding

Graph/Chart) II-15

International Initiatives in the Proteomics Market II-15

China All Set To Play a Major Role in the Proteomics Industry II-16

Global Proteomics Sample Preparation Market - On a Growth Curve II-16

Challenges Facing Proteomics Sample Preparation Market II-17

Industrialization of Proteomics Research Propels Sample

Preparation Technologies II-17

Factors Limiting Market Growth II-17

Impact of the Economic Recession on the Life Sciences Industry

in Retrospect II-17

Challenges Facing Proteomics Industry II-18

Protein Chemistry and its Complexities II-18

Quantitation II-18

Integration of Data & Equipment II-18

Data Validation - A Burning Issue II-19

Standardization & Consistency - A Prime Concern II-19

Incomplete and Disorganized Data II-19

 

2. INDUSTRY COMPETITION II-20

A Highly Fragmented Market II-20

Tool Providers: Leading the Proteomics Market II-21

Role of Contract Research Organizations - All Set to Increase

in Proteomics II-21

 

3. PRODUCT AND TECHNOLOGY OVERVIEW II-22

Proteins, Proteome and Proteomics!!! - What are they? II-22

Proteomics - An Introduction II-22

Genesis of Proteomics II-23

Components of Proteomics II-24

Expression Proteomics II-24

Functional Proteomics II-24

Cell-map Proteomics II-24

Structural Proteomics II-24

Technologies and Proteomics II-24

Proteomics and Genomics II-25

Proteomics and Genomics: A Comparison II-25

Protein Production Pathway: From Gene Expression to

Functional Protein with Controls II-25

From Genomics to Proteomics II-26

Functional Genomics and Proteomics II-26

Push from Genomic Information II-27

An Insight into Proteomics Data Type and their

Characteristics / Features II-27

Standard Proteomics Approach II-27

Sample Preparation - Step I II-28

Protein Separation - Step II II-28

Protein Visualization II-28

Protein Expression Analysis-Step III II-28

Image Analysis - Identify differentially expressed spots II-28

Protein Identification - Step IV II-29

Data Storage and Processing - Step V II-29

 

4. OVERVIEW OF PROTEOMICS TECHNOLOGIES II-30

A Snapshot of Various Proteomics Tools II-30

An Insight into Various Proteomics Technologies and their

Application Areas II-30

Protein Separation II-30

2-Dimensional Gel Electrophoresis (2DGE) II-31

Elements of 2-DE Proteomics II-31

Two -Dimensional Differential Gel Electrophoresis II-31

Combining 2D Gel Electrophoresis with Mass Spectrometry (MS) II-31

2D Capillary LC II-32

Analytical Strength of LC-MS and MS/MS in Shotgun Protein

Sequencing II-32

Protein Characterization II-32

Analysis of Protein through Mass Spectrometry II-32

MS and Proteins II-32

Comparison of MS Techniques II-33

Applications of MS II-33

Problems Associated with MS II-34

Types of Analyzers or Filters II-34

MALDI-TOF MS II-34

MS/MS II-34

SELDI-TOF II-34

Laser Capture Microdissection II-35

Tandem MS II-35

Y2H, Yeast 2-Hybrid System II-35

Sensitivity of Two-Hybrid Assays II-35

Limitations of Y2H II-36

Protein Microarrays II-36

Market Influencers in Protein Microarrays Market II-36

Chip Technology II-36

Microfluidic Applications II-37

Role of Bioinformatics in Proteomics II-37

Bioinformatics Applications and Tools in Proteomics II-37

MS Programs II-37

2- DE gel Comparison II-38

2-DE Databases II-38

Databases of 2D-electrophoretic maps II-38

Emerging Proteomics Technologies II-39

MudPIT II-39

ICAT II-39

ICAT strategy: A solution to quantitative proteome analysis II-39

Phage Display Technique II-39

Advanced Proteomics Technologies: Structural Analysis Tools II-40

X-ray Crystallography II-40

Nuclear Magnetic Resonance (NMR) II-40

In silico Modelling II-40

Physicochemical Factors Constraining Metabolic Functions II-41

 

5. END-USE APPLICATION AREAS II-42

Proteomics in Drug Discovery and Diagnostics II-43

Proteomics and Drug Discovery II-43

Protein Microarrays: A New Tool for the Development of

Pharmaceuticals II-44

Proteomic Approaches Gain Prominence in Cancer Drug Discovery II-44

Proteomics Technologies Used in Cancer Drug Discovery and

Development II-45

 

6. NEW PRODUCT LAUNCHES/DEVELOPMENTS II-46

Proteome Sciences Validates Novel Protein Biomarkers II-46

KineMed to Apply Its MS Proteomics Platform to Study

Neurodegeneration II-46

Agilent and MRM Proteomics Introduce PeptiQuant Kits for High

-Quality Plasma Proteomic Analysis II-46

Elsevier Launches 'Translational Proteomics' Open-Access Journal II-46

Applied Biomics Introduces Global Protein Post- Translational

Modification Profiling Service II-46

AB SCIEX Launches New Column Chips II-47

Applied Biomics Introduces New Mass Spectrometry Service II-48

Norton Scientific Introduces Novel Specialist Applications

Development Laboratory Service II-48

Gentel Biosciences Introduces APiX™ Disease Profiling Kit II-48

Integromics Introduces OmicsHub Proteomics 2.0 II-49

Bruker Introduces amaZon Speed Ion Trap Mass Spectrometers II-49

Applied Biomics Introduces iTRAQ Service for Proteomics Research II-50

Norton Scientifc Introduces New Lab Support Service for Rapid

RNA/DNA and Protein Measurement II-50

Bruker Launches MALDI Biotarget™ II-51

Thermo Fisher Launches UHLPC System II-51

Kinexus Introduces Human Gene Online TranscriptoNET KnowledgeBase II-52

Bruker Launches PRIME Integrated Proteomics Solution II-52

Applied Biosystems Launches LS*LIMS Laboratory Automation

Technology for Proteomics and Genomics II-53

Kinexus Bioinformatics Introduces Online KiNET-AM Proteomics

DataBase II-53

Bruker Rolls Out CaptiveSpray Electrospray Ion Source for

Proteomics Applications II-54

Thermo Fisher Launches New Capabilities for Performing

Proteomics Workflows II-54

National Cancer Institute Introduces Clinical Proteomic Tumor

Analysis Consortium for Cancer Studies II-55

KinaSorb™ - New Kit for Kinase Enrichment II-55

 

7. RECENT INDUSTRY ACTIVITY II-56

Retroscreen Virology Group Acquires Activiomics II-56

Thermo Fisher Scientific Acquires Life Technologies Corporation II-56

Fluidigm Corporation Buys DVS Sciences II-56

Geneva Bioinformatics Collaborates with University of Washington II-56

Applied Proteomics Partners with German Research Institute II-56

Agilent Technologies Enters Agreement with SomaLogic II-57

Biognosys Partners with CellnTEC II-57

Proteome Sciences Enters Contract with Thermo Fisher Scientific II-57

Agilent Technologies Partners with Sera Prognostics II-57

Chicago Growth Partners Buys Caprion Proteomics from Thallion II-57

GlaxoSmithKline Fully Acquires Cellzome II-58

Proteome Sciences Signs Agreement with CHDI Foundation II-58

Waters Corp. Inks Agreement with Nonlinear Dynamics II-58

BioFocus Enters into Alliance with Activiomics II-58

Great Point Partners Divests Caprion Proteomics II-59

Glaxo Smith Kline Takes over Cellzome II-59

Emerald BioSystems Changes Name to Emerald Bio II-59

Bruker Unveils Novel Nano-Advance UHPLC System II-60

Evotec Takes Over Kinaxo Biotechnologies II-60

Kinaxo Biotechnologies and AstraZeneca Sign Agreement II-60

Gentel Biosciences Takes over Eppendorf's SilverQuant Trademark II-60

Thermo Fisher Takes Over Fermentas International II-61

KINAXO to Collaborate with Takeda II-61

Dualsystems and Bulldog Bio Signs Exclusive Marketing Agreement II-61

Novartis Enters into Agreement with SomaLogic II-62

Sage-N Inks Exclusive Pact with the U.S. Army II-62

Proteome Sciences Inks Agreement with Moffitt Cancer Center II-62

Gentel Biosciences Enters into Agreement with Oregon Health &

Science University II-62

Evotec OAI Forms Joint Venture with MeITec to Collaborate on

Drug Discovery Services II-63

 

8. FOCUS ON SELECT KEY PLAYERS II-64

ActivX Biosciences, Inc. II-64

Agilent Technologies, Inc. II-64

Bio-Rad Laboratories, Inc. II-64

Bruker Daltonics, Inc. II-65

Caprion Proteomics, Inc. II-66

Digilab Genomic Solutions, Inc. II-66

GE Healthcare II-67

Geneva Bioinformatics S.A. II-67

Hybrigenics SA II-68

EMD Millipore/Merck Millipore Corp. II-68

PerkinElmer, Inc. II-68

Shimadzu Corporation II-69

Sigma-Aldrich Corporation II-69

Thermo Fisher Scientific II-70

Waters Corp. II-70

Xencor Inc. II-71

 

9. GLOBAL MARKET PERSPECTIVE II-72

Table 11: World Recent Past, Current & Future Analysis for

Proteomics by Geographic Region - US, Canada, Japan, Europe,

Asia-Pacific, Latin America, and Rest of World Markets

Independently Analyzed with Annual Sales Figures in US$

Million for Years 2013 through 2020 (includes corresponding

Graph/Chart) II-72

 

Table 12: World Historic Review for Proteomics by Geographic

Region - US, Canada, Japan, Europe, Asia-Pacific, Latin

America, and Rest of World Markets Independently Analyzed with

Annual Sales Figures in US$ Million for Years 2006 through

2012 (includes corresponding Graph/Chart) II-73

 

Table 13: World 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

US, Canada, Japan, Europe, Asia-Pacific, Latin America, and

Rest of World Markets for Years 2006, 2014 and 2020 (includes

corresponding Graph/Chart) II-74

 

 

III. MARKET

 

1. THE UNITED STATES III-1

A.Market Analysis III-1

Current & Future Analysis III-1

Personalized Medicine - A Major Driver for the Proteomics

Market III-1

Table 14: US Market for Hospital Cancer Therapies by

Treatment Type (2004 and 2010): Percentage Breakdown of

Revenues for Surgery, Chemotherapy Drugs, Radiation

Therapy, Biotechnology-Based Drugs, and Others (includes

corresponding Graph/Chart) III-2

Cancer Presumes Epidemic Proportion in the US III-2

Table 15: New Cancer Cases by Gender and Affected Site in

the US (2013) III-3

Proteomics to Provide POCT for Patients in Hospice Care III-4

Leading Market for Rapid and Automated Microbiological Tests III-4

Demographic Changes Offer Growth Opportunities III-5

Table 16: North American Aging Population by Age Group:

1975-2050 (includes corresponding Graph/Chart) III-5

Proteomics Sample Preparation Market III-6

FDA's Antidote III-6

New Product Launches III-6

Strategic Corporate Developments III-12

Key Players III-18

B.Market Analytics III-24

Table 17: The US Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-24

 

Table 18: The US Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-25

 

2. CANADA III-26

A.Market Analysis III-26

Rising Incidence of Chronic Diseases Spurs Proteomics Demand III-26

Table 19: New Cancer Cases in Canada by Gender and Affected

Site (2012) (includes corresponding Graph/Chart) III-27

 

Table 20: New Cancer Cases in Canada by Province (2012)

(includes corresponding Graph/Chart) III-28

 

Table 21: New Cancer Cases in Canada by Age Group and

Gender (2012) (includes corresponding Graph/Chart) III-29

New Product Developments III-30

Strategic Corporate Development III-31

Caprion proteomics, Inc. - A Key Player III-31

B.Market Analytics III-32

Table 22: Canadian Recent Past, Current & Future Analysis

for Proteomics Market Analyzed with Annual Sales Figures in

US$ Million for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-32

 

Table 23: Canadian Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-33

 

3. JAPAN III-34

A.Market Analysis III-34

Demographics Drive Market Growth III-34

Table 24: Percentage Breakdown of Japanese Population by

Age Group (2012) (includes corresponding Graph/Chart) III-34

Table 25: Over 65 Years Population in Japan (1950-2010)

(includes corresponding Graph/Chart) III-35

Shimadzu Corp. - A Key Player III-35

B.Market Analytics III-36

Table 26: Japanese Recent Past, Current & Future Analysis

for Proteomics Market Analyzed with Annual Sales Figures in

US$ Million for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-36

 

Table 27: Japanese Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-37

 

4. EUROPE III-38

A.Market Analysis III-38

Debt Crisis in Europe Affects Healthcare Industry III-38

European Healthcare System: In a State of Transition? III-38

Cancer Trends III-38

Table 28: Cancer Incidence in Europe by Site: 2012 (in

Thousands) (includes corresponding Graph/Chart) III-39

Aging Population to Drive Demand for Proteomics III-40

Table 29: Population Breakup by Age Group for Select

European Countries: 2012 (As a % of Total Population)

(includes corresponding Graph/Chart) III-40

European Personalized Medicine Market to Exhibit Robust Growth III-41

Proteomics Market in Europe III-41

Table 30: European Proteomics Market (2013): Percentage

Breakdown of Deployment of Proteomics Technologies in

End-Use Segment - Research and Academic Institutions,

Pharmaceutical Companies, and Clinical Laboratories

(includes corresponding Graph/Chart) III-41

Proteomics Research in Europe - An Overview III-41

Protein Identification Market III-42

Protein Separation Market III-43

Market Challenges III-43

Gaining Edge in the Proteomics Industry - Player Strategies III-43

European 2DE Market - Benefiting from Recession III-44

New Product Developments III-44

Strategic Corporate Developments III-45

Select Key Players III-47

B.Market Analytics III-49

Table 31: European Recent Past, Current & Future Analysis

for Proteomics by Geographic Region - France, Germany,

Italy, UK and Rest of Europe Markets Independently Analyzed

with Annual Sales Figures in US$ Million for Years 2013

through 2020 (includes corresponding Graph/Chart) III-49

 

Table 32: European Historic Review for Proteomics by

Geographic Region - France, Germany, Italy, UK and Rest of

Europe Markets Independently Analyzed with Annual Sales

Figures in US$ Million for Years 2006 through 2012 (includes

corresponding Graph/Chart) III-50

 

Table 33: European 15-Year Perspective for Proteomics by

Geographic Region - Percentage Breakdown of Dollar Sales for

France, Germany, Italy, UK and Rest of Europe Markets for

Years 2006, 2014 and 2020 (includes corresponding

Graph/Chart) III-51

 

4a. FRANCE III-52

A.Market Analysis III-52

French Proteomics Player - Hybrigenics Sa III-52

B.Market Analytics III-53

Table 34: French Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-53

 

Table 35: French Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-54

 

4b. GERMANY III-55

Market Analysis III-55

Table 36: German Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-55

 

Table 37: German Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-56

 

4c. ITALY III-57

Market Analysis III-57

Table 38: Italian Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-57

 

Table 39: Italian Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-58

 

4d. THE UNITED KINGDOM III-59

A.Market Analysis III-59

Highlights III-59

Increased Support for Personalized Medicine to Drive

Proteomics Demand III-59

Strategic Corporate Development III-59

Key Player - Ge Healthcare III-60

B.Market Analytics III-61

Table 40: The UK Recent Past, Current & Future Analysis for

Proteomics Market Analyzed with Annual Sales Figures in US$

Million for Years 2013 through 2020 (includes corresponding

Graph/Chart) III-61

 

Table 41: The UK Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-62

 

4e. REST OF EUROPE III-63

A.Market Analysis III-63

Key Swiss Player - Geneva Bioinformatics S.A. III-63

B.Market Analytics III-63

Table 42: Rest of European Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-63

 

Table 43: Rest of European Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-64

 

5. ASIA-PACIFIC III-65

A.Market Analysis III-65

Healthcare Spending in Asia-Pacific: On the Rise III-65

China III-65

Table 44: China - The Most Populous Country Worldwide (July

2013): Total Population (in Millions) by Age Group 0-14

Years, 15-44 Years, 45-64 Years, and 65+ Years for China

Vis-a-Vis Other Countries (includes corresponding

Graph/Chart) III-66

 

Table 45: China - The Most Populous Country Worldwide (July

2013): Percentage Population by Age Group 0-14 Years, 15-44

Years, 45-64 Years, and 65+ Years for China Vis-a-Vis Other

Countries (includes corresponding Graph/Chart) III-67

Government Support Drives Personalized Medicine Market in China III-67

Australia III-68

India III-68

Indian Scientific Research towards Functional Genomics and

Proteomics III-68

B.Market Analytics III-69

Table 46: Asia-Pacific Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-69

 

Table 47: Asia-Pacific Historic Review for Proteomics Market

Analyzed with Annual Sales Figures in US$ Million for Years

2006 through 2012 (includes corresponding Graph/Chart) III-70

 

6. LATIN AMERICA III-71

Market Analysis III-71

Table 48: Latin American Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-71

 

Table 49: Latin American Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-72

 

7. REST OF WORLD III-73

Market Analysis III-73

Table 50: Rest of World Recent Past, Current & Future

Analysis for Proteomics Market Analyzed with Annual Sales

Figures in US$ Million for Years 2013 through 2020 (includes

corresponding Graph/Chart) III-73

 

Table 51: Rest of World Historic Review for Proteomics

Market Analyzed with Annual Sales Figures in US$ Million for

Years 2006 through 2012 (includes corresponding Graph/Chart) III-74

 

 

IV. COMPETITIVE LANDSCAPE

 

Total Companies Profiled: 82 (including Divisions/Subsidiaries - 85)

 

The United States (54)

Canada (4)

Japan (2)

Europe (24)

- France (3)

- Germany (6)

- The United Kingdom (7)

- Spain (1)

- Rest of Europe (7)

Asia-Pacific (Excluding Japan) (1)

 

 

 

To order this report: Global Proteomics Market

http://www.reportlinker.com/p092466/Global-Proteomics-Market.html

__________________________

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source

Best of Content We Love 2014 


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.